Please see below to view details for this session presenter

Rahul Singhvi, ScD, MBA

Managing Director, Caliber Biotherapeutics

Dr. Singhvi is a business leader in the vaccine and biotechnology industry.  He is Managing Director of G-Con, LLC, an emerging biotechnology company in Bryan, Texas.  Before joining G-Con, Dr. Singhvi served as the President & CEO of Novavax, Inc, a NASDAQ listed, development stage biotechnology company.   Under his leadership, Novavax’s valuation rose from $35M to almost $300M and enjoyed a robust pipeline of important clinical and preclinical stage vaccine candidates, including those against influenza, respiratory syncytial virus (RSV), and other infectious diseases. Dr. Singhvi graduated as the top ranked chemical engineer from IIT, Kanpur, India and obtained both his MS and ScD degrees in chemical engineering from MIT.  He also received an MBA degree from the Wharton School of the University of Pennsylvania where he graduated as a Palmer Scholar.